Abstract
AbstractTADS results show fluoxetine plus CBT safer and more effective for teen depression.Levetiracetam does not improve behavioral disturbances associated with autism.Somatic symptoms in children with anxiety disorders.Atomoxetine for ADHD with ODD.FDA adds young adults to black box warning on antidepressants.Risperidone vs. quetiapine for disruptive behavior.SSRIs and early adolescent suicide.Study: Prenatal nicotine exposure and ADHD‐I.Epileptiform seizure with sertraline.Approval: Risperidone for irritability with autism.Precaution: Neuropsychiatric events with tamiflu.Label revision: Overdosage risk with venlafaxine.Approval: quetiapine for bipolar depression.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
